Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The bile salt glycocholate induces global changes in gene and protein expression and activates virulence in enterotoxigenic Escherichia coli.

Joffre E, Nicklasson M, Álvarez-Carretero S, Xiao X, Sun L, Nookaew I, Zhu B, Sjöling Å.

Sci Rep. 2019 Jan 14;9(1):108. doi: 10.1038/s41598-018-36414-z.

2.

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML.

Delsing Malmberg E, Johansson Alm S, Nicklasson M, Lazarevic V, Ståhlman S, Samuelsson T, Lenhoff S, Asp J, Ehinger M, Palmqvist L, Brune M, Fogelstrand L.

Leuk Lymphoma. 2019 Feb;60(2):409-417. doi: 10.1080/10428194.2018.1485910. Epub 2018 Aug 2.

PMID:
30068244
3.

Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia.

Bernson E, Hallner A, Sander FE, Nicklasson M, Nilsson MS, Christenson K, Aydin E, Liljeqvist JÅ, Brune M, Foà R, Aurelius J, Martner A, Hellstrand K, Thorén FB.

Cancer Immunol Res. 2018 Sep;6(9):1110-1119. doi: 10.1158/2326-6066.CIR-17-0711. Epub 2018 Jul 6.

4.

A prospective study of female genital chronic graft-versus-host disease symptoms, signs, diagnosis and treatment.

Smith Knutsson E, Björk Y, Broman AK, Helström L, Nicklasson M, Brune M, Sundfeldt K.

Acta Obstet Gynecol Scand. 2018 Sep;97(9):1122-1129. doi: 10.1111/aogs.13366. Epub 2018 Jun 5.

PMID:
29752810
5.

Draft genomes of four enterotoxigenic Escherichia coli (ETEC) clinical isolates from China and Bangladesh.

Liu F, Yang X, Wang Z, Nicklasson M, Qadri F, Yi Y, Zhu Y, Lv N, Li J, Zhang R, Guo H, Zhu B, Sjöling Å, Hu Y.

Gut Pathog. 2015 Apr 8;7:10. doi: 10.1186/s13099-015-0059-z. eCollection 2015.

6.

Molecular characterization of multidrug resistant hospital isolates using the antimicrobial resistance determinant microarray.

Leski TA, Vora GJ, Barrows BR, Pimentel G, House BL, Nicklasson M, Wasfy M, Abdel-Maksoud M, Taitt CR.

PLoS One. 2013 Jul 25;8(7):e69507. doi: 10.1371/journal.pone.0069507. Print 2013.

7.

The impact of individual quality of life assessment on psychosocial attention in patients with chest malignancies: a randomized study.

Nicklasson M, Elfström ML, Olofson J, Bergman B.

Support Care Cancer. 2013 Jan;21(1):87-95. doi: 10.1007/s00520-012-1496-6. Epub 2012 May 31.

PMID:
22644259
8.

Expression of colonization factor CS5 of enterotoxigenic Escherichia coli (ETEC) is enhanced in vivo and by the bile component Na glycocholate hydrate.

Nicklasson M, Sjöling Å, von Mentzer A, Qadri F, Svennerholm AM.

PLoS One. 2012;7(4):e35827. doi: 10.1371/journal.pone.0035827. Epub 2012 Apr 30.

9.

Clonal relatedness of enterotoxigenic Escherichia coli (ETEC) strains expressing LT and CS17 isolated from children with diarrhoea in La Paz, Bolivia.

Rodas C, Klena JD, Nicklasson M, Iniguez V, Sjöling A.

PLoS One. 2011;6(11):e18313. doi: 10.1371/journal.pone.0018313. Epub 2011 Nov 29.

10.

Enterotoxigenic Escherichia coli multilocus sequence types in Guatemala and Mexico.

Nicklasson M, Klena J, Rodas C, Bourgeois AL, Torres O, Svennerholm AM, Sjoling A.

Emerg Infect Dis. 2010 Jan;16(1):143-6. doi: 10.3201/eid1601.090979.

11.

Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6.

Tobias J, Lebens M, Källgård S, Nicklasson M, Svennerholm AM.

Vaccine. 2008 Oct 3;26(42):5373-80. doi: 10.1016/j.vaccine.2008.07.091. Epub 2008 Aug 15.

PMID:
18708110
12.

Mutations in the periplasmic chaperone leading to loss of surface expression of the colonization factor CS6 in enterotoxigenic Escherichia coli (ETEC) clinical isolates.

Nicklasson M, Sjöling A, Lebens M, Tobias J, Janzon A, Brive L, Svennerholm AM.

Microb Pathog. 2008 Mar;44(3):246-54. Epub 2007 Oct 18.

PMID:
18037262
13.
14.

In vivo expression of the heat stable (estA) and heat labile (eltB) toxin genes of enterotoxigenic Escherichia coli (ETEC).

Sjöling A, Qadri F, Nicklasson M, Begum YA, Wiklund G, Svennerholm AM.

Microbes Infect. 2006 Oct;8(12-13):2797-802. Epub 2006 Sep 12.

PMID:
17045506
15.

Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans.

Nicklasson M, Björkman S, Roth B, Jönsson M, Höglund P.

Chirality. 2002 Aug;14(8):643-52.

PMID:
12125034
16.

Bioavailability of benzo(a)pyrene deposited in the lung. Correlation with dissolution from urban air particulates and covalently bound DNA adducts.

Törnquist S, Nicklasson M, Söderkvist P, Nybom L, Toftgård R.

Drug Metab Dispos. 1988 Nov-Dec;16(6):842-7.

PMID:
2907463
17.

Optimization of a fluid bed spray coating process using reduced factorial design.

Johansson ME, Ringberg A, Nicklasson M.

J Microencapsul. 1987 Jul-Sep;4(3):217-22.

PMID:
3504507
18.
19.

Program for evaluating drug dissolution kinetics in preformulation.

Nicklasson M, Magnusson AB.

Pharm Res. 1985 Nov;2(6):262-6. doi: 10.1023/A:1016333432224.

PMID:
24271121
20.

Influence of epimer ratio on physicochemical properties of bacampicillin hydrochloride.

Nyqvist H, Nicklasson M.

Acta Pharm Suec. 1985;22(4):229-36. No abstract available.

PMID:
4061108
21.

Preformulation studies in a drug development program for tablet formulations.

Graffner C, Johansson ME, Nicklasson M, Nyqvist H.

J Pharm Sci. 1985 Jan;74(1):16-20.

PMID:
3981410
22.

Linear systems analysis and moment analysis in the evaluation of bacampicillin bioavailability from microcapsule suspensions.

Nicklasson M, Ellström K, Sjöqvist R, Sjövall J.

J Pharmacokinet Biopharm. 1984 Oct;12(5):467-78.

PMID:
6520743
23.

Correlations between in vitro dissolution rate and bioavailability of alaproclate tablets.

Graffner C, Nicklasson M, Lindgren JE.

J Pharmacokinet Biopharm. 1984 Aug;12(4):367-80.

PMID:
6527230
24.

Prediction of light-induced discoloration of tablets from accelerating test conditions by means of numerical convolution.

Nyqvist H, Nicklasson M.

Acta Pharm Suec. 1984;21(6):367-72. No abstract available.

PMID:
6534073
25.

Studies on the physical properties of tablets and tablet excipients. V. Film coating for protection of a light-sensitive tablet-formulation.

Nyqvist H, Nicklasson M, Lundgren P.

Acta Pharm Suec. 1982;19(3):223-8. No abstract available.

PMID:
7113729
26.

Studies on a rotating disk method to determine drug dissolution rates from inert PVC matrices.

Nicklasson M, Brodin A, Graffner C.

Acta Pharm Suec. 1982;19(3):211-22. No abstract available.

PMID:
7113728
27.

The coating of disk surfaces by tablet lubricants, determined by an intrinsic rate of dissolution method.

Nicklasson M, Brodin A.

Acta Pharm Suec. 1982;19(2):99-108. No abstract available.

PMID:
7102356
28.

Studies on the physical properties of tablets and tablet excipients. IV. A program for accelerated light stability testing.

Nyqvist H, Nicklasson M, Lundgren P, Fyhr AS, Stjernfelt U.

Acta Pharm Suec. 1982;19(2):91-8. No abstract available.

PMID:
7102355
29.

A rotating disk method to study the influence of binding agents on the dissolution rate.

Nicklasson M, Brodin A.

Acta Pharm Suec. 1982;19(2):119-26. No abstract available.

PMID:
7102350
30.

Supplemental Content

Loading ...
Support Center